2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎
反馈给我们。基本信息 | 登录收藏 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | ONCOLOGIST ONCOLOGIST (此期刊被最新的JCR期刊SCIE收录) LetPub评分 7.5
58人评分
我要评分
声誉 8.6 影响力 6.7 速度 6.8 | |||||||||||||||||||||
期刊ISSN | 1083-7159 | 微信扫码收藏此期刊 | ||||||||||||||||||||
E-ISSN | 1549-490X | |||||||||||||||||||||
2023-2024最新影响因子 (数据来源于搜索引擎) | 4.8 点击查看影响因子趋势图 | |||||||||||||||||||||
实时影响因子 | 截止2024年3月26日:4.776 | |||||||||||||||||||||
2023-2024自引率 | 4.20%点击查看自引率趋势图 | |||||||||||||||||||||
五年影响因子 | 5.3 | |||||||||||||||||||||
JCI期刊引文指标 | 1.03 | |||||||||||||||||||||
h-index | 145 | |||||||||||||||||||||
CiteScore ( 2024年最新版) |
| |||||||||||||||||||||
期刊简介 |
| |||||||||||||||||||||
期刊官方网站 | http://theoncologist.alphamedpress.org/ | |||||||||||||||||||||
期刊投稿网址 | https://www.editorialmanager.com/TO | |||||||||||||||||||||
期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足ONCOLOGIST的语言要求,还能让ONCOLOGIST编辑和审稿人得到更好的审稿体验,让稿件最大限度地被ONCOLOGIST编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||
是否OA开放访问 | No | |||||||||||||||||||||
通讯方式 | ALPHAMED PRESS, 318 BLACKWELL ST, STE 260, DURHAM, USA, NC, 27701-2884 | |||||||||||||||||||||
出版商 | AlphaMed Press | |||||||||||||||||||||
涉及的研究方向 | 医学-肿瘤学 | |||||||||||||||||||||
出版国家或地区 | UNITED STATES | |||||||||||||||||||||
出版语言 | English | |||||||||||||||||||||
出版周期 | Monthly | |||||||||||||||||||||
出版年份 | 1996 | |||||||||||||||||||||
年文章数 | 317点击查看年文章数趋势图 | |||||||||||||||||||||
Gold OA文章占比 | 79.47% | |||||||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 87.07% | |||||||||||||||||||||
WOS期刊SCI分区 ( 2023-2024年最新版) | WOS分区等级:1区
| |||||||||||||||||||||
中国科学院《国际期刊预警 名单(试行)》名单 | 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||
中国科学院SCI期刊分区 ( 2023年12月最新升级版) | 点击查看中国科学院SCI期刊分区趋势图
| |||||||||||||||||||||
中国科学院SCI期刊分区 ( 2022年12月升级版) |
| |||||||||||||||||||||
中国科学院SCI期刊分区 ( 2021年12月旧的升级版) |
| |||||||||||||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1083-7159%5BISSN%5D | |||||||||||||||||||||
平均审稿速度 | 网友分享经验: 一般,3-8周 | |||||||||||||||||||||
平均录用比例 | 网友分享经验: 较难 | |||||||||||||||||||||
LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在ONCOLOGIST顺利发表。
快看看作者怎么说吧:服务好评 论文致谢 | |||||||||||||||||||||
期刊常用信息链接 |
|
|
|
中国学者近期发表的论文 | |
1. | Association Between Lymphopenia and Survival Outcomes in Esophageal Carcinoma Patients Receiving Combined Immunotherapy and Chemoradiotherapy Author: Cheng, Xingyuan; Chen, Baoqing; Wang, Sifen; Zhang, Jun; Zhu, Jinhan; Liu, Mengzhong; Liu, Shiliang; Xi, Mian Journal: ONCOLOGIST. 2023; Vol. , Issue , pp. -. DOI: 10.1093/oncolo/oyad094 PubMed DOI |
2. | Radiotherapy Plus Temozolomide With or Without Nimotuzumab Against the Newly Diagnosed EGFR-Positive Glioblastoma: A Retrospective Cohort Study Author: She, Lei; Gong, Xuan; Su, Lin; Liu, Chao Journal: ONCOLOGIST. 2023; Vol. 28, Issue 1, pp. E45-E53. DOI: 10.1093/oncolo/oyac202 PubMed DOI |
3. | Adjuvant Abemaciclib Combined with Endocrine Therapy: Efficacy Results in monarchE Cohort 1 Author: Toi, Masakazu; Boyle, Frances; Im, Young-Hyuck; Reinisch, Mattea; Molthrop, David; Jiang, Zefei; Wei, Ran; Sapunar, Francisco; Grimes, Brenda R.; Nabinger, Sarah Cassidy; Johnston, Stephen R. D. Journal: ONCOLOGIST. 2023; Vol. 28, Issue 1, pp. E77-E81. DOI: 10.1093/oncolo/oyac234 PubMed DOI |
4. | Safety and Clinical Activity of SHR7390 Monotherapy or Combined With Camrelizumab for Advanced Solid Tumor: Results From Two Phase I Trials Author: Wei, Xiao-Li; Zhang, Yang; Zhao, Hong-Yun; Fang, Wen-Feng; Luo, Hui-Yan; Qiu, Miao-Zhen; He, Ming-Ming; Zou, Ben-Yan; Xie, Jie; Jin, Chun-Lei; Zhou, Xian-Feng; Wang, Feng; Wang, Feng-Hua; Li, Yu-Hong; Wang, Zhi-Qiang; Xu, Rui-Hua Journal: ONCOLOGIST. 2023; Vol. 28, Issue 1, pp. E36-E44. DOI: 10.1093/oncolo/oyac225 PubMed DOI |
5. | Nab-paclitaxel Followed by Dose-dense Epirubicin/Cyclophosphamide in Neoadjuvant Chemotherapy for Triple-negative Breast Cancer: A Phase II Study Author: Liu, Yin; Fan, Lei; Wang, Zhong-Hua; Shao, Zhi-Ming Journal: ONCOLOGIST. 2023; Vol. 28, Issue 1, pp. 86-+. DOI: 10.1093/oncolo/oyac223 PubMed DOI |
6. | The Mutational, Prognostic, and Therapeutic Landscape of Neuroendocrine Neoplasms Author: Liu, Man; Li, Na; Tang, Hongzhen; Chen, Luohai; Liu, Xuemei; Wang, Yu; Lin, Yuan; Luo, Yanji; Wei, Shaozhen; Wen, Wenli; Chen, Minhu; Wang, Jiaqian; Zhang, Ning; Chen, Jie Journal: ONCOLOGIST. 2023; Vol. , Issue , pp. -. DOI: 10.1093/oncolo/oyad093 PubMed DOI |
7. | Perioperative Chemotherapy Could Not Improve the Prognosis of Gastric Cancer Patients With Mismatch Repair Deficiency: A Multicenter, Real-World Study Author: Zhao, Lulu; Fu, Yongliang; Niu, Penghui; Zhang, Fan; Jiao, Fuzhi; Zhou, Xiadong; Wu, Zhenkun; Wang, Wanqing; Luan, Xiaoyi; Han, Xue; He, Mingyan; Guan, Quanlin; Li, Yumin; Zhao, Dongbing; Gao, Jidong; Chen, Yingtai Journal: ONCOLOGIST. 2023; Vol. , Issue , pp. -. DOI: 10.1093/oncolo/oyad108 PubMed DOI |
8. | Development of a Multivariate Prognostic Model for Lenvatinib Treatment in Hepatocellular Carcinoma Author: Li, Xiaomi; Ding, Xiaoyan; Liu, Mei; Wang, Jingyan; Li, Wei; Chen, Jinglong Journal: ONCOLOGIST. 2023; Vol. , Issue , pp. -. DOI: 10.1093/oncolo/oyad107 PubMed DOI |
9. | Clinical Outcomes of Afatinib Versus Osimertinib in Patients With Non-Small Cell Lung Cancer With Uncommon EGFR Mutations: A Pooled Analysis Author: Wang, Chunsheng; Zhao, Kewei; Hu, Shanliang; Dong, Wei; Gong, Yan; Xie, Conghua Journal: ONCOLOGIST. 2023; Vol. , Issue , pp. -. DOI: 10.1093/oncolo/oyad111 PubMed DOI |
10. | Prevalence and Associations of Beta2-Microglobulin Mutations in MSI-H/dMMR Cancers Author: Liu, Fangcen; Zhong, Fangfang; Wu, Huan; Che, Keying; Shi, Jiaochun; Wu, Nandie; Fu, Yao; Wang, Yue; Hu, Jing; Qian, Xiaoping; Fan, Xiangshan; Wang, Weifeng; Wei, Jia Journal: ONCOLOGIST. 2023; Vol. , Issue , pp. -. DOI: 10.1093/oncolo/oyac268 PubMed DOI |
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2024 中国: LetPub上海 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室